Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Side Effects With Lung Cancer Chemotherapy More Common in Older Patients
Link ID 21789
Title Side Effects With Lung Cancer Chemotherapy More Common in Older Patients
Url http://www.medscape.com/viewarticle/715329?src=rss
Description Older patients receiving chemotherapy for advanced non-small-cell lung cancer (NSCLC) experience more adverse events than younger patients, according to a study published online December 28th in the Journal of Clinical Oncology. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Jan 20, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Thera
  Inoperable non-small-cell lung cancer (NSCLC) treatments can have highly toxic side effects. Can the risk-benefit ratio be improved with a maximally tolerated dosing regimen? Clinical Lung Cancer
Category:   Articles > Pharmacists


2. Folic Acid Antagonist Exposure Raises Risk of Pregnancy Complications
  Mothers exposed to folic acid antagonists during the 1-year period before delivery have a higher risk of placenta-mediated adverse outcomes, according to a paper from Canada. Reuters Health Information
Category:   Articles > Pharmacists


3. Deferasirox Reduces Iron Burden in Aplastic Anemia
  Oral therapy with the iron-chelating agent deferasirox (Exjade) is effective in patients with aplastic anemia, researchers report in a June 21st online paper in Blood. Reuters Health Information
Category:   Articles > Pharmacists


4. Cyclophosphamide Improves Scleroderma but Benefits Wane
  One year of treatment with cyclophosphamide results in significant improvements in lung function, skin scores, dyspnea, and quality of life in patients with scleroderma lung disease, new findings indicate. While these effects persist for several months after treatment cessation, they are generally no longer apparent after 24 months. Reuters Health Information
Category:   Articles > Pharmacists


5. Gabapentin: A Multimodal Perioperative Drug?
  A growing body of evidence suggests that perioperative administration of gabapentin is efficacious and safe in the perioperative setting.
British Journal of Anaesthesia
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS